Kaoru Tsuchiya
18PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Nov 03, 2025
Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENT.Kazuomi Ueshima, Kaoru Tsuchiya, Tatsuya Yamashita
|Oct 14, 2025
Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older.Kenta Takaura, Kaoru Tsuchiya, Mina Taguchi
|Sep 11, 2025
Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter Study.Yasuyuki Komiyama, Nobuharu Tamaki, Keiji Tsuji
|May 03, 2025
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group.Keiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki
|Feb 24, 2024
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver disease.Nobuharu Tamaki, Shun-Ichi Wakabayashi, Takefumi Kimura
|Jan 18, 2024
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.Keito Suzuki, Nobuharu Tamaki, Masayuki Kurosaki
Pageof 3
Frequent Collaborators
8 joint publications
Nobuharu Tamaki
7 joint publications
Masayuki Kurosaki
4 joint publications
Shun Kaneko
4 joint publications
Yutaka Yasui
4 joint publications
Kenta Takaura
3 joint publications
Sakura Kirino
2 joint publications
Hiroyuki Nakanishi
2 joint publications
Hironori Ochi
2 joint publications
Chikara Ogawa
2 joint publications
Masatoshi Kudo
